Tumor cells frequently hijack this system by upregulating BCAA transporters, stabilizing BCAT isoforms, and modulating BCKDH activity, thereby reprogramming BCAA catabolism to support biosynthesis, bioenergetics, and oncogenic signaling. The gene discussed is PPM1K; the disease is neoplasm.